Ace the Case: A 76-Year-Old Male With Active Neovascular Age-Related Macular Degeneration

Overview

Provider Statement

This continuing education activity is provided by 

Support Statement

This activity is supported by an educational grant from Genentech, a member of the Roche Group.

Activity Description

In this clinical case review, Dr. Arshad Khanani explores options for switching treatment in a patient with neovascular age-related macular degeneration (nAMD) who has become nonresponsive to anti-vascular endothelial growth factor (VEGF) therapy.

Target Audience

The intended audience for this activity is retina specialists, comprehensive ophthalmologists, and other healthcare professionals involved in the management of patients with nAMD and diabetic macular edema (DME).

Learning Objectives

Upon successful completion of this activity, participants should be better able to:

• Utilize assessment techniques and tools that aid in determining patients who would benefit from injectables that offer extended intervals between treatments in nAMD.
• Select treatment protocols that improve adherence to therapy in patients with nAMD.

Faculty

Arshad M. Khanani, MD, MA, FASRS
Managing Partner
Director of Clinical Research
Director of Fellowship
Sierra Eye Associates
Clinical Associate Professor
University of Nevada
Reno, NV

Medical Writer

Amy E. Cyr, MD
St. Louis, MO

Planner/Reviewer

Ronald A. Codario, MD, EMBA, FACP, FNLA, RPVI, CHCP

Accreditation

In support of improving patient care, Vindico Medical Education is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Credit Designation

Vindico Medical Education designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

This enduring material is approved for 1 year from the date of original release, June 30, 2023, to June 29, 2024.

How to Participate in This Activity and Obtain CE Credit

To participate in this activity, you must read the objectives, answer the polling and pretest questions, view the case, and complete the posttest and evaluation. Provide only one (1) correct answer for each question. A satisfactory score is defined as answering the posttest question correctly. If a satisfactory score on the posttest is achieved, Vindico Medical Education will issue an AMA PRA Category 1 Credit(s)™ certificate.

Disclosures

Vindico Medical Education adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a continuing education activity, including faculty, planners, reviewers, or others, are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.

Relationship information is accurate at the time of content development.

Faculty reports the following relevant financial relationship(s)

Arshad M. Khanani, MD, MA, FASRS
Consultant: 4DMT, Adverum, Alimera, Allergan, Apellis, AsclepiX, Aviceda, Bausch + Lomb, Broadwing Bio, Chengdu Kanghong, Cholgene, DORC, Gemini, Genentech, Glaukos, Graybug, Gyroscope, Iveric Bio, Janssen, Kato, Kodiak, Novartis, Oculis, Opthea, Oxurion, PolyPhotonix, RecensMedical, Regeneron, Retrotope, Regenxbio, RevOpsis, Roche, Thea, Unity Bio
Speaker Contracted by Ineligible Company: Allergan, Genentech, Novartis
Independent Research Contractor: 4DMT, Adverum, Apellis, AsclepiX, Chengdu Kanghong, Gemini, Genentech, Graybug, Gyroscope, Iveric Bio, Kodiak, Neurotech, NGM Bio, Novartis, Ocular Therapeutix, Oculis, Opthea, Oxurion, RecensMedical, Regenxbio, Roche, Unity Bio
Individual Stocks and Stock Options: Aviceda, PolyPhotonix, RecensMedical, Retrotope

Medical Writer reports the following relevant financial relationship(s)

Amy E. Cyr, MD
No relevant financial relationships to disclose.

Planner/Reviewer reports the following relevant financial relationship(s)

Ronald A. Codario, MD, EMBA, FACP, FNLA, RPVI, CHCP
No relevant financial relationships to disclose.

Vindico Medical Education staff report the following relevant financial relationship(s)

No relevant financial relationships to disclose.

Signed disclosures are on file at Vindico Medical Education, Office of Medical Affairs and Compliance.

Unlabeled and Investigational Usage

The audience is advised that this continuing education activity may contain references to unlabeled uses of FDA-approved products or to products not approved by the FDA for use in the United States. The faculty members have been made aware of their obligation to disclose such usage. All activity participants will be informed if any speakers/authors intend to discuss either non–FDA-approved or investigational use of products/devices.

Copyright Statement

Created and published by Vindico Medical Education, 6900 Grove Road, Building 100, Thorofare, NJ 08086-9447. Telephone: 856-994-9400; Fax: 856-384-6680. Printed in the USA. Copyright © 2023 Vindico Medical Education. All rights reserved. No part of this publication may be reproduced without written permission from the publisher. The material presented at or in any Vindico Medical Education continuing education activity does not necessarily reflect the views and opinions of Vindico Medical Education. Neither Vindico Medical Education nor the faculty endorse or recommend any techniques, commercial products, or manufacturers. The faculty/authors may discuss the use of materials and/or products that have not yet been approved by the FDA. All readers and continuing education participants should verify all information before treating patients or utilizing any product.

CE Questions?

Contact us at cme@vindicoCME.com